Are You Worried About HER2+ Breast Cancer Recurrence?

YOU are your first advocate. Don’t be afraid to ask your healthcare team questions to make sure you’re doing everything you can to help reduce your risk of HER2+ breast cancer recurrence. Talk to your doctor today and take a stand against HER2+ breast cancer recurrence with NERLYNX. NERLYNX is an oral medication taken for 1-year after trastuzumab-based therapy that may help to reduce your risk of HER2+ breast cancer.

NERLYNX can cause side effects, including diarrhea which can be serious.

Please see Important Safety Information: https://nerlynx.com/

Patient Information: https://nerlynx.com/pdf/nerlynx_product_information_download.pdf